Allurion Technologies (ALUR) Operating Income (2022 - 2026)
Allurion Technologies (ALUR) posted Operating Income of -$3.7 million for Q1 2026, up 40.37% on a QoQ basis from -$6.3 million in Q4 2025, and up 48.76% year-over-year from -$2.5 million in Q1 2025.
Allurion Technologies (ALUR) Operating Income (2022 - 2026) Analysis & Trends
Allurion Technologies' Operating Income history runs 5 years deep, the most recent figure standing at -$3.7 million for Q1 2026.
- Quarterly Operating Income rose 48.76% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.6 million (up 42.34% YoY) and the FY2025 annual result came in at -$30.2 million, up 39.92% from the prior year.
- Operating Income was -$3.7 million for Q1 2026 at Allurion Technologies, up from -$6.3 million in the prior quarter.
- Across five years, Operating Income topped out at -$3.7 million in Q1 2026 and bottomed at -$26.2 million in Q3 2023.
- A 5-year average of -$11.8 million and a median of -$10.8 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income sank 209.67% — and 2025, when it jumped 63.44%.
- Allurion Technologies' Operating Income stood at -$10.1 million in 2022, then slumped by 153.63% to -$25.7 million in 2023, then surged by 33.5% to -$17.1 million in 2024, then soared by 63.44% to -$6.3 million in 2025, then jumped by 40.37% to -$3.7 million in 2026.
- Business Quant data shows ALUR's Operating Income at -$3.7 million in Q1 2026, -$6.3 million in Q4 2025, and -$9.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.73 Mn |
| Dec 31, 2025 | -6.26 Mn |
| Sep 30, 2025 | -9.63 Mn |
| Jun 30, 2025 | -6.95 Mn |
| Mar 31, 2025 | -7.28 Mn |
| Dec 31, 2024 | -17.12 Mn |
| Sep 30, 2024 | -12.34 Mn |
| Jun 30, 2024 | -9.35 Mn |
| Mar 31, 2024 | -11.39 Mn |
| Dec 31, 2023 | -25.74 Mn |
| Sep 30, 2023 | -26.15 Mn |
| Jun 30, 2023 | -13.29 Mn |
| Mar 31, 2023 | -13.90 Mn |
| Dec 31, 2022 | -10.15 Mn |
| Sep 30, 2022 | -11.99 Mn |
| Jun 30, 2022 | -4.29 Mn |